Merck & Co., Inc.

10% owner at Harpoon Therapeutics, Inc. · on record since Jan 17, 2024
10% owner at Personalis, Inc. · on record since Dec 23, 2024
10% owner at CapForce Inc. · on record since Jul 23, 2015
10% owner at BeOne Medicines Ltd. · on record since Feb 10, 2016
10% owner at Organon & Co. · on record since May 7, 2021
10% owner at Yarrow Bioscience, Inc. · on record since Jan 24, 2018
10% owner at INTREorg SYSTEMS INC. · on record since Jun 4, 2021
10% owner at SUTRO BIOPHARMA, INC. · on record since Sep 26, 2018
10% owner at NGM BIOPHARMACEUTICALS INC · on record since Apr 9, 2019
10% owner at ARQULE INC · on record since Dec 16, 2019
10% owner at Pandion Therapeutics, Inc. · on record since Mar 4, 2021

Insider trading activity of Merck & Co., Inc.

Transactions on record: 12; since May 24, 2016

Open-market buys: 3; $568.1M

Open-market sells: 0

Companies traded: 5; last filing Mar 11, 2024

Figures computed from official regulatory filings — .

Companies where Merck & Co., Inc. has traded

Harpoon Therapeutics, Inc.1 tx · $492.1M · Mar 11, 2024
INTREorg SYSTEMS INC.1 tx · Jun 4, 2021
NGM BIOPHARMACEUTICALS INC3 tx · $65.9M · Apr 9, 2019
SUTRO BIOPHARMA, INC.3 tx · $10M · Oct 2, 2018
4 tx · Feb 8, 2018

Track record of Merck & Co., Inc.

Statistical track record

Free account

Open-market buys: 5

Last buy: Mar 11, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Merck & Co., Inc.

Co-insiders of Merck & Co., Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Harpoon Therapeutics, Inc.Listing unverified	Mar 11, 2024	Buy	21,397,205	23.00 USD	$492.1M	conv 70First in 12mo	SEC
INTREorg SYSTEMS INC.Listing unverified	Jun 4, 2021	Other	-253,516,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 9, 2019	Buy	4,121,683	16.00 USD	$65.9M	conv 59Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 9, 2019	Other	8,833,333	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 9, 2019	OtherD (derivative)	-17,666,666	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	Other	2,056,843	—	n/a (No price was disclosed in the filing)		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	Buy	666,666	15.00 USD	$10M	conv 50First in 12mo	SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-74,794,315	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CapForce Inc.Listing unverified	Feb 8, 2018	AwardD (derivative)	13,120	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CapForce Inc.Listing unverified	May 24, 2016	Award	1,200,000	—	n/a (No price was disclosed in the filing)		SEC
CapForce Inc.Listing unverified	May 24, 2016	BuyD (derivative)	900,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
CapForce Inc.Listing unverified	May 24, 2016	BuyD (derivative)	2,734,427	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Harpoon Therapeutics, Inc.Listing unverified	Mar 11, 2024	Buy	21,397,205	23.00 USD	$492.1M	conv 70First in 12mo	SEC
INTREorg SYSTEMS INC.Listing unverified	Jun 4, 2021	Other	-253,516,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 9, 2019	Buy	4,121,683	16.00 USD	$65.9M	conv 59Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 9, 2019	Other	8,833,333	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 9, 2019	OtherD (derivative)	-17,666,666	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	Other	2,056,843	—	n/a (No price was disclosed in the filing)		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	Buy	666,666	15.00 USD	$10M	conv 50First in 12mo	SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-74,794,315	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CapForce Inc.Listing unverified	Feb 8, 2018	AwardD (derivative)	13,120	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CapForce Inc.Listing unverified	May 24, 2016	Award	1,200,000	—	n/a (No price was disclosed in the filing)		SEC
CapForce Inc.Listing unverified	May 24, 2016	BuyD (derivative)	900,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
CapForce Inc.Listing unverified	May 24, 2016	BuyD (derivative)	2,734,427	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC